Immunochemotherapy: The new standard in aggressive non-Hodgkin's lymphoma in the elderly

被引:23
|
作者
Coiffier, B
机构
[1] Hospices Civils Lyon, Lyon, France
[2] Univ Lyon 1, F-69365 Lyon, France
关键词
D O I
10.1053/sonc.2003.50021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:21 / 27
页数:7
相关论文
共 50 条
  • [41] New drugs in non-Hodgkin's lymphoma
    Arbuck, SG
    Sorensen, JM
    Christian, MC
    Ho, P
    Pluda, JM
    Cheson, BD
    ANNALS OF ONCOLOGY, 1997, 8 : 119 - 128
  • [42] Early therapy monitoring with FDG-PET in aggressive non-Hodgkin’s lymphoma and Hodgkin’s lymphoma
    Tatsuo Torizuka
    Fumitoshi Nakamura
    Toshihiko Kanno
    Masami Futatsubashi
    Etsuji Yoshikawa
    Hiroyuki Okada
    Masahide Kobayashi
    Yasuomi Ouchi
    European Journal of Nuclear Medicine and Molecular Imaging, 2004, 31 : 22 - 28
  • [43] Hodgkin's and Non-Hodgkin's Lymphoma
    Manning, Jaye
    CANCER FORUM, 2007, 31 (02) : 117 - 117
  • [44] Early therapy monitoring with FDG-PET in aggressive non-Hodgkin's lymphoma and Hodgkin's lymphoma
    Torizuka, T
    Nakamura, F
    Kanno, T
    Futatsubashi, M
    Yoshikawa, E
    Okada, H
    Kobayashi, M
    Ouchi, Y
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (01) : 22 - 28
  • [45] Role of anemia in survival of elderly aggressive non-Hodgkin's lymphoma patients following chemotherapy.
    Zinzani, PL
    Tani, M
    Molinari, AL
    Visani, G
    Gentilini, P
    Guardigni, L
    Stefoni, V
    Alinari, L
    Marchi, E
    Gabriele, A
    Musuraca, G
    Fina, MP
    Baccarani, M
    BLOOD, 2004, 104 (11) : 906A - 906A
  • [46] Standard approaches to relapsed indolent non-Hodgkin's lymphoma
    Witzig, Thomas E.
    SEMINARS IN HEMATOLOGY, 2007, 44 (03) : S12 - S17
  • [47] Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: Is there a chance for cure?
    Josting, A
    Reiser, M
    Rueffer, U
    Salzberger, B
    Diehl, V
    Engert, A
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (02) : 332 - 339
  • [48] Aggressive therapy for leptomeningeal involvement in Non-Hodgkin's Lymphoma.
    Ginzburg, AZ
    Buckstein, R
    Imrie, KR
    BLOOD, 2002, 100 (11) : 571A - 571A
  • [49] Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin's lymphoma
    Ziepert, M.
    Schmits, R.
    Trumper, L.
    Pfreundschuh, M.
    Loeffler, M.
    ANNALS OF ONCOLOGY, 2008, 19 (04) : 752 - 762
  • [50] A systematic overview of chemotherapy effects in aggressive non-Hodgkin's lymphoma
    Kimby, E
    Brandt, L
    Nygren, P
    Glimelius, B
    ACTA ONCOLOGICA, 2001, 40 (2-3) : 198 - 212